Condition
Allograft Rejection
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 4 (2)
Trial Status
Completed4
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03984747Completed
Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection
NCT01957696Enrolling By Invitation
The Norwegian Pancreas Transplantation (PTx) Study
NCT01212406Phase 4CompletedPrimary
Vitamin D in Bronchiolitis Obliterans Syndrome
NCT01820897Phase 4Completed
Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation
NCT00382486Completed
Low Dose Irradiation for Small Bowel Transplant
Showing all 5 trials